May 1, 1998Neurology24 citations
Neurologists' attitudes regarding rt-PA for acute ischemic stroke
View Full Paper
Structured PICO
P
Population
238 Texas neurologists
I
Intervention
Survey regarding the use of recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke
O
Outcome
Attitudes regarding the use of rt-PA
Soon after FDA approval, a majority of surveyed Texas neurologists were using or planning to use rt-PA for acute ischemic stroke and reported positive experiences.
Abstract
We studied the attitudes of 238 Texas neurologists regarding the use of recombinant tissue plasminogen activator (rt-PA). The results show that 38 (16%) had treated stroke patients with rt-PA, and 97% of these would do so again. In the group that had not treated patients, 60% would treat if a suitable candidate presented. We conclude that soon after FDA approval of rt-PA, two-thirds of survey respondents were using or were planning to use this therapy. Those neurologists who have used rt-PA for stroke report a positive experience.